Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics

Yoshiyuki Suehara, Naobumi Tochigi, Daisuke Kubota, Kazutaka Kikuta, Robert Nakayama, Kunihiko Seki, Akihiko Yoshida, Hitoshi Ichikawa, Tadashi Hasegawa, Kazuo Kaneko, Hirokazu Chuman, Yasuo Beppu, Akira Kawai, Tadashi Kondo

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


We aimed to develop prognostic biomarkers for synovial sarcoma employing a proteomic approach. We examined the proteomic profile of synovial sarcoma using two-dimensional difference gel electrophoresis (2D-DIGE). We identified 20 protein spots whose intensity was statistically different (p < 0.01) between a group of eight patients who were alive and continuously disease-free for over five years and a group of five patients who died of the disease within two years post diagnosis. Mass spectrometric protein identification demonstrated that these 20 spots corresponded to 17 distinct gene products. Three of the 20 spots corresponded to secernin-1 and had higher intensity in the good prognosis group. The prognostic performance of secernin-1 was further examined immunohistochemically in 45 synovial sarcoma cases. The 5-year survival rate was 77.6% and 21.8% for patients with secernin-1 positive and negative primary tumors respectively (p = 0.0015). The metastasis-free survival was significantly higher in the patient group with high secernin-1 expression compared to that with low expression (p = 0.0012). Uni- and multivariate analyses revealed that secernin-1 expression was a powerful prognostic factor compared to other clinico-pathological parameters examined. These results indicate that secernin-1 may be used as a biomarker to predict the overall and metastasis-free survival in synovial sarcoma patients.

Original languageEnglish
Pages (from-to)829-842
Number of pages14
JournalJournal of Proteomics
Issue number6
Publication statusPublished - 2011 May 16


  • 2D-DIGE
  • Proteomics
  • Secernin-1
  • Synovial sarcoma

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry


Dive into the research topics of 'Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics'. Together they form a unique fingerprint.

Cite this